Upcoming Presentations and Webinars

Our experts attend and participate in scientific, clinical and business meetings around the world. To learn more about an upcoming event or to schedule a meeting, info@evidera.com.

  • Upcoming Webinars

    Webinar

    Post-Authorization Safety Studies (PASS) for the Evaluation of Risk Minimization in the EU

    Presenters: Annalisa Rubino, PhD, Senior Research Scientist, Real-World Evidence, Evidera
    Wednesday, October 18 2017, 10:00 AM ET

    Registration Link

    Webinar

    Patient-Centered Research in the Era of Patient-Focused Drug Development

    Presenters: Heather Gelhorn, PhD, Senior Research Scientist, Outcomes Research, Evidera; Hilary Wilson, PhD, Director of Patient Engagement, Outcomes Research, Evidera
    Tuesday, October 31 2017, 10:00 AM ET

    Registration Link

  • Upcoming Presentations

    • October 22 - 25, 2017
      Pittsburgh, PA, USA

      Short Course

      DICE Simulation for Health Care Decision-Analytic Modeling

      Authors/Presenters: Caro JJ, Moller J

    • October 24 - , 2017
      Online

      Webinar

      Do Patient Preference Have a Role in Health Technology Assessment? Current Practice and Future Potential

      Authors/Presenters: Marsh K

    • October 25 - 26, 2017
      Basel, Switzerland

      Workshop

      How Can RWD Uncover Real Unmet Medical Needs in R&D Process?

      Authors/Presenters: Katarzyna K, Wasiak R

    • October 31 - November 4, 2017
      Venice, Italy

      Poster

      Caregiver Burden Associated with Extremely Preterm Birth

      Authors/Presenters: Sarda S, Lenderking W, Pokrzywinski R, Stringer S, Mangili A

    • November 1 - 4, 2017
      Boston, MA, USA

      Poster

      Validating Trial Power in Presence of Non-Random Dropouts Using Disease Simulation

      Authors/Presenters: Tafazzoli A, Quon PL, Stern S, Kansal A

    • November 4 - 8, 2017
      Glasgow, Scotland

      Short Course

      Using DICE Simulation for Health Economic Analyses

      Authors/Presenters: Caro JJ, Moller J

      Short Course

      Using Multi-Criteria Decision Analysis in Health Care Decision Making: Approaches & Applications

      Authors/Presenters: IJzerman M J, Marsh K, Devlin N

      Workshop

      W8: Modeling Separate Lines of Treatment Versus Treatment Sequences in Cancer

      Authors/Presenters: Benedict A, Stevenson M, Sorensen S

      Workshop

      W9: Patients' Preferences in the European Regulatory Environment: A Critical Review

      Authors/Presenters: Mühlbacher A, Marsh K, Van Til J

      Issue Panel

      IP11: Determining Value in Health Technology Assessment Consistent with Societal Aims: Pursue New Options?

      Authors/Presenters: Caro, JJ, McGuire A, Brazier J, Schlander M

      Issue Panel

      IP24: Trusting the Results of Model-Based Economic Analyses: Is There a Pragmatic Validation Solution?

      Authors/Presenters: Caro JJ, Stevenson M, Moller J, Ghabri S

      Issue Panel

      IP28: Patient Preferences in European Drug Regulation - Are We Ready?

      Authors/Presenters: Postmus D, Pignatti F, Demolis P, Tervonen T

      ISPOR Forum

      F2: Methods and Preliminary Results of the ISPOR Oncology Health Economic Modeling Special Interest Group

      Authors/Presenters: Muszbek N, Benedict A, Iannazzo S, Nabil Ashoush N, Qureshi H

      Podium Presentation

      RM3: Methods for Extracting Treatment Patterns for Renal Cell Carcinoma (RCC) From Social Media (SM) Forums Using Natural Language Processing (NLP) and Machine Learning (ML)

      Authors/Presenters: Merinopoulou E, Ramagopalan S, Malcolm B, Cox A

      Poster

      PCN46: A Systemic Literature Review of UK Epidemiology of BRCA1 and BRCA2-Mutated Locally Advanced Or Metastatic Ovarian Cancer

      Authors/Presenters: Bedel D, Ricci V, Sarri G, Lavaud V

      Poster

      PCN59: Matching Adjusted Indirect Comparison of Sunitinib and Everolimus for the Treatment of Pancreatic Neuroendocrine Tumours (PNETS)

      Authors/Presenters: Ishak J, Rael M, Hicks M, Mittal S, Eatock M, Valle JW

      Poster

      PCN163: Cost-Effectiveness of Ibrutinib in Patients with Relapsed OR Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

      Authors/Presenters: Hassan F, Peng S, Dorman E, Sorensen S, Thompson G, Lee J

      Poster

      PCN165: Economic Evaluation of Nivolumab (NIVO) plus Ipilimumab (IPI) combination as First-line Treatment for Patients with Advanced Melanoma in Canada

      Authors/Presenters: Quon P, Xiao Y, Sorensen S, Schultz M, Tahami Monfared AA

      Poster

      PCN166: Modelling the Effectiveness of Ibrutinib Versus Physician's Choice (PC) in Relapsed OR Refractory (RR) Waldenstrom's Macroglobulinemia (WM) Within England

      Authors/Presenters: Guillermin A, Hassan F, Sydnor S, Peng S, Proskorovsky I, Sorensen S, Thompson G, Lee J

      Poster

      PCN200: Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

      Authors/Presenters: Matza L, Deger K, Howell T, Hillgruber N, Yeager A, Hogge D, Fisher V, Louie A, Chung K

      Poster

      PCN221: Moving PRO Measures from the Promise to Impact in Oncology Clinical Practice: Results from a Systematic Literature Review

      Authors/Presenters: Anatchkova M, Skalicky AM, Whiteley J, Jagun D, McHorney C, Donelson SM

      Poster

      PDB37: Cost-Effectiveness Analysis of Empagliflozin in the Treatment of T2D with Previous Cardiovascular Disease in Italy

      Authors/Presenters: Iannazzo S, Mannucci E, Reifsnider O, Maggioni AP

      Poster

      PDB56: Evaluating Patients' Preferences for Dulaglutide Versus Insulin Glargine Profiles in the United Kingdom: A Discrete Choice Experiment

      Authors/Presenters: Norrbacka K, Poon JL, Boye K, Thieu VT, Hassan SW, Gelhorn HL

      Poster

      PUK18: Sentiment Analysis of Social Media Posts from Renal Cell Carcinoma (RCC) Patients

      Authors/Presenters: Merinopoulou E, Ramagopalan S, Malcolm B, Lees M, Cox A

      Poster

      PCV115: The Effect of Changing Utility Elicitation Methods in Cardiovascular Disease: A Systematic Literature Review

      Authors/Presenters: Betts M, Rane P, Bergrath E, Chitnis M, Gulea C, Qian Y, Villa G

      Poster

      PCV166: Real-World Treatment Patterns Among Patients Initiating on Statins in England

      Authors/Presenters: Lambrelli D, Merinopoulou E, Donaldson R, Mardekian J, Hlavacek P, Tarasenko L, Masseria C, Hobbs FDR

      Poster

      PGI4: Incidence of Surgery for Inflammatory Bowel Disease Within 12 Months of Initiation of Vedolizumab or Infliximab

      Authors/Presenters: Patel H, Raluy-Callado M, Berger A, Carroll R, Khalid JM

      Poster

      PMD105: Patient Preferences in Italy: Health State Utilities Associated with Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

      Authors/Presenters: Matza L, Boye K, Jordan J, Norrbacka K, Gentilella R, Browne C, Federici M, Stewart K

      Poster

      PHP304: Challenges and Future Perspectives on the Reimbursement of Advanced Therapy Medicinal Products

      Authors/Presenters: Rothwell S, January D, Duda M, Gardner K, Michel S

      Poster

      PND35: Cost-effectiveness Analysis of PegInterferon Beta-1a vs. First-line Injectable Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis in Spain

      Authors/Presenters: Ruiz L, Toro-Diaz H, Cele C, Hernandez L, Harrington A

      Poster

      PND36: Cost-Effectiveness Analysis of Daclizumab Beta Versus Fingolimod for the Treatment of Multiple Sclerosis from a Spanish Payer Perspective

      Authors/Presenters: Ruiz L, Marchado M, Toro-Diaz H, Xaplanteris L

      Poster

      PND39: Cost-Effectiveness Analysis of Dimethyl Fumerate Versus Teriflunomide for the Treatment of Multiple Sclerosis

      Authors/Presenters: Ruiz L, Marchada M, Toro-Diaz H, Cele C, Hernandez L, Harrington A

      Poster

      PIN22: Budget Impact of Introducing Ceftazidime-Avibactam for Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections, and Hospital Acquired Pneumonia Including Ventilator-Associated Pneumonia to a Hospital Formulary in Italy

      Authors/Presenters: Kongnakorn T, Tichy E, Merinopoulou E, Berto P, Di Virgilio R, Charbonneau C

      Poster

      PRM13: Statistical Methods for Critical Care Outcomes

      Authors/Presenters: Exuzides A, Filonenko A, Kunz M, Gerlinger C, Chu BC, Bhurke S, Sites S

      Poster

      PRM62: Comparison of ICD-9 to ICD-10 Crosswalks Derived by Physician and Clinical Coder Vs. Automated Methods

      Authors/Presenters: Simeone J, Bhagnani T, Rhodes T, Reynolds M

      Poster

      PRM103: Representing Uncertainty in Economic Evaluations: Getting More from PSA Results

      Authors/Presenters: Oguz M, Lanitis T

      Poster

      PRM127: Incorporating Dependence Between Model Parameters in Uncertainty Analyses

      Authors/Presenters: Oguz M, Roiz J

      Poster

      PRM133: Calibrating Model-Consistent Transition Probabilities for Fibrosis Stages in NASH

      Authors/Presenters: Gal P, Roiz J, Xiao Y

      Poster

      PRM207: Minimizing Bias in Parametric Survival Analyses of Published Kaplan-Meier Curves

      Authors/Presenters: Rael M, Ishak J

      Poster

      PRM217: An Accessible Comparison of Traditional Statistical and Machine Learning Approaches to Analysis of Real World Data: Which, When and Why

      Authors/Presenters: Merinopoulou E, Oguz M, Chu BC, McDonald L, Ulvestad M, Cox A, Ramagopalan S

      Poster

      PRM218: Minimizing Bias in Indirect Comparisons Utilizing Virtual Patient Level Data

      Authors/Presenters: Rael M, Iskak J

      Poster

      PRM235: What's the Reality of Real-World Evidence in Health Technology Appraisal

      Authors/Presenters: Sarri G, Lambrelli D, Gulea C, Gomez Espinosa E, Iheanacho I

      Poster

      PRM253: A Robust, Reproducible Method for Evaluating the Suitability of Disparate Observational Databases for Pooled Analysis, Using the OMOP Common Data Model

      Authors/Presenters: Reisinger S, McDonald L, Carroll R, O’Hara D, Anstatt D, Ramagopalan S

    • December 4 - 8, 2017
      Abu Dhabi

      Poster

      Evaluating Patients’ Preferences for Dulaglutide versus Insulin Glargine Medication Profiles in Subgroups of People with Type 2 Diabetes

      Authors/Presenters: Thieu VT, Poon JL, Gelhorn H, Wasi-Hassan S, Norrbacka K, Boye KS

Back to Top